Therapeutic Efficacy Comparison of a Six-month Treatment by Itraconazole and Nebulised Ambisome Versus Treatment by Itraconazole Alone in Non- or Mildly- Immunocompromised Patients With Chronic Pulmonary Aspergillosis: a Prospective, Randomized, Single Blind Study, (Single Aspergilloma Excluded)
Phase of Trial: Phase III
Latest Information Update: 24 Jun 2019
Price : $35 *
At a glance
- Drugs Amphotericin B liposomal (Primary) ; Itraconazole (Primary) ; Posaconazole; Voriconazole
- Indications Aspergillosis; Invasive bronchopulmonary aspergillosis
- Focus Therapeutic Use
- Acronyms CPAAARI
- 05 Apr 2019 Planned End Date changed from 1 May 2023 to 1 Jul 2023.
- 05 Apr 2019 Planned primary completion date changed from 1 May 2021 to 1 Jun 2021.
- 05 Apr 2019 Status changed from not yet recruiting to recruiting.